ah 6809 has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hijikata, T; Ichikawa, H; Morimoto, Y; Takahashi, T; Tsuneyama, K | 1 |
| Bando, Y; Izumi, K; Ogawa, H; Takahashi, T; Uehara, H; Umemoto, H | 1 |
| Abruzzese, JL; Cognetti, F; McConkey, DJ; Nawrocki, ST; Pino, MS; Xiong, HQ | 1 |
3 other study(ies) available for ah 6809 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Inhibition of EP2/EP4 prostanoid receptor-mediated signaling suppresses IGF-1-induced proliferation of pancreatic cancer BxPC-3 cells via upregulating γ-glutamyl cyclotransferase expression.
Topics: Cell Line, Tumor; Cell Proliferation; gamma-Aminobutyric Acid; gamma-Glutamylcyclotransferase; Humans; Insulin-Like Growth Factor I; Isoindoles; Metabolome; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Sulfonamides; Up-Regulation; Xanthones | 2019 |
Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Enzyme Activation; Humans; Insulin-Like Growth Factor I; Isoindoles; Mice; Mice, Nude; Pancreatic Neoplasms; Protein Kinase C-delta; Receptor Cross-Talk; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Xanthones; Xenograft Model Antitumor Assays | 2015 |
Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.
Topics: Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Models, Biological; Pancreatic Neoplasms; Phosphorylation; Prostaglandin Antagonists; Sulfonamides; Xanthones | 2005 |